
Alicia L. Otton
Examiner (ID: 9618)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1699, 4121 |
| Total Applications | 1585 |
| Issued Applications | 975 |
| Pending Applications | 99 |
| Abandoned Applications | 544 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18233181
[patent_doc_number] => 11597729
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Tropomyosin receptor kinase inhibitor, preparation method therefor and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/044791
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10135
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044791
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044791 | Tropomyosin receptor kinase inhibitor, preparation method therefor and use thereof | Jun 5, 2019 | Issued |
Array
(
[id] => 16794106
[patent_doc_number] => 20210123923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION ASSOCIATED WITH NEPHROTOXICITY
[patent_app_type] => utility
[patent_app_number] => 15/734581
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734581 | METHODS OF MONITORING, TREATING, AND PREVENTING RENAL INFLAMMATION ASSOCIATED WITH NEPHROTOXICITY | Jun 5, 2019 | Abandoned |
Array
(
[id] => 16892050
[patent_doc_number] => 11033577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Polymer conjugate of hexa-coordinated platinum complex
[patent_app_type] => utility
[patent_app_number] => 16/431811
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23823
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 567
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431811
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/431811 | Polymer conjugate of hexa-coordinated platinum complex | Jun 4, 2019 | Issued |
Array
(
[id] => 16892050
[patent_doc_number] => 11033577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Polymer conjugate of hexa-coordinated platinum complex
[patent_app_type] => utility
[patent_app_number] => 16/431811
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23823
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 567
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431811
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/431811 | Polymer conjugate of hexa-coordinated platinum complex | Jun 4, 2019 | Issued |
Array
(
[id] => 16743237
[patent_doc_number] => 10968211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Hepatitis B core protein modulators
[patent_app_type] => utility
[patent_app_number] => 16/426727
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 151487
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 558
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16426727
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/426727 | Hepatitis B core protein modulators | May 29, 2019 | Issued |
Array
(
[id] => 17156065
[patent_doc_number] => 20210317116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => N-1 BRANCHED CYCLOALKYL SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/250073
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17250073
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/250073 | N-1 branched cycloalkyl substituted imidazo[4,5-c]quinoline compounds, compositions, and methods | May 22, 2019 | Issued |
Array
(
[id] => 14990973
[patent_doc_number] => 20190314444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => ETBR ANTAGONIST COMPOUNDS, COMPOSITIONS, AND USES
[patent_app_type] => utility
[patent_app_number] => 16/419931
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419931
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/419931 | ETBR ANTAGONIST COMPOUNDS, COMPOSITIONS, AND USES | May 21, 2019 | Abandoned |
Array
(
[id] => 17243407
[patent_doc_number] => 20210363150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => ARYL TRIAZOLE CAGES
[patent_app_type] => utility
[patent_app_number] => 16/965283
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16965283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/965283 | Aryl triazole cages | May 21, 2019 | Issued |
Array
(
[id] => 14806097
[patent_doc_number] => 20190269658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => PHARMACEUTICAL COMPOSITIONS DIRECTLY TARGETING FKBP52 FOR THE TREATMENT OF PROSTATE CANCER AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/415141
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415141
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/415141 | Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same | May 16, 2019 | Issued |
Array
(
[id] => 14774863
[patent_doc_number] => 20190262329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => MUSCARINIC ANTAGONISTS AND COMBINATIONS THEREOF FOR THE TREATMENT OF AIRWAY DISEASE IN HORSES
[patent_app_type] => utility
[patent_app_number] => 16/406918
[patent_app_country] => US
[patent_app_date] => 2019-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16406918
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/406918 | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses | May 7, 2019 | Issued |
Array
(
[id] => 16222710
[patent_doc_number] => 20200247826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-06
[patent_title] => COMPOUND AND COLOR CONVERSION FILM COMPRISING SAME, BACKLIGHT UNIT, AND DISPLAY DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/652250
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7141
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652250
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652250 | Compound and color conversion film comprising same, backlight unit, and display device | Apr 29, 2019 | Issued |
Array
(
[id] => 14723123
[patent_doc_number] => 20190252625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => ORGANIC LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING MATERIAL AND COMPOUND USED THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/394055
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/394055 | ORGANIC LIGHT-EMITTING DEVICE, AND LIGHT-EMITTING MATERIAL AND COMPOUND USED THEREFOR | Apr 24, 2019 | Abandoned |
Array
(
[id] => 16657343
[patent_doc_number] => 20210053979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => MACROCYCLIC TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/043886
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 289
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17043886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/043886 | Macrocyclic toll-like receptor 7 (TLR7) agonists | Apr 22, 2019 | Issued |
Array
(
[id] => 14684921
[patent_doc_number] => 20190241575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => TYK2 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/382734
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 294834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382734
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382734 | TYK2 inhibitors and uses thereof | Apr 11, 2019 | Issued |
Array
(
[id] => 14684925
[patent_doc_number] => 20190241577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => TYK2 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/382907
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 297022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382907
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382907 | TYK2 inhibitors and uses thereof | Apr 11, 2019 | Issued |
Array
(
[id] => 14746691
[patent_doc_number] => 20190256519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => TYK2 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/382680
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 296744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382680
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382680 | TYK2 inhibitors and uses thereof | Apr 11, 2019 | Issued |
Array
(
[id] => 15512661
[patent_doc_number] => 10562906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => TYK2 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/382824
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 298107
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382824 | TYK2 inhibitors and uses thereof | Apr 11, 2019 | Issued |
Array
(
[id] => 15512663
[patent_doc_number] => 10562907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => TYK2 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/382869
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 298272
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382869
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382869 | TYK2 inhibitors and uses thereof | Apr 11, 2019 | Issued |
Array
(
[id] => 15649555
[patent_doc_number] => 20200087307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => BICYCLIC COMPOUNDS AS ATX INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/380909
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16380909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/380909 | Bicyclic compounds as ATX inhibitors | Apr 9, 2019 | Issued |
Array
(
[id] => 17822618
[patent_doc_number] => 11427554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Lactone compound and novel ether compound
[patent_app_type] => utility
[patent_app_number] => 17/044080
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23156
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044080 | Lactone compound and novel ether compound | Apr 7, 2019 | Issued |